Main sponsors

Seit seiner Gründung im Jahr 2010 hat sich die Moderna Inc. mit Hauptsitz in Cambridge, Mass. (USA), von einem forschungsorientierten Unternehmen, das auf dem Gebiet der Messenger-RNA (mRNA) tätig ist, zu einem mRNA-Pionier und weltweit bekannten Biotechnologieunternehmen entwickelt. Das klinische Portfolio im Bereich der mRNA-Imfstoffe und -Therapeutika erstreckt sich über sechs verschiedene Forschungsgebiete. Zudem verfügt das Unternehmen über Patente in Bereichen wie der Formulierung von mRNA und Lipid-Nano-Partikeln (LNPs). Eigens entwickelte Produktionsanlagen ermöglichen eine flexible und schnelle Produktion von Impfstoffen und Therapeutika.  

Moderna arbeitet weltweit mit einer Vielzahl an Partnern zusammen, um neben bahnbrechender Wissenschaft auch eine schnelle Skalierung der Produktion zu ermöglichen. Das Know-how von Moderna und der unermüdliche Einsatz aller Mitarbeitenden haben zur Zulassung einer der ersten wirksamen mRNA-Impfstoffe zur COVID-19-Pandemiebekämpfung geführt.  

Die mRNA-Plattform von Moderna basiert auf kontinuierlichen Fortschritten in der Grundlagen- und angewandten mRNA-Forschung, den Applikationsformen sowie der Herstellung. Sie ermöglicht die Entwicklung von Therapeutika und Impfstoffen für Infektionskrankheiten, in der Immunonkologie, gegen seltene Krankheiten, Herz-Kreislauf-Erkrankungen und Autoimmunerkrankungen.  

2022 wurde Moderna von Science zum achten Mal in Folge als einer der besten Arbeitgeber in der globalen biopharmazeutischen Industrie ausgezeichnet. 

QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins the building blocks of life. We enable our customers to unlock valuable insights from any biological sample be it blood, a throat swab or many other materials. Our products for molecular testing serve a wide range of applications from basic life sciences research to clinical healthcare. Our reputation is based on confidence in decisions, clarity of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success.
Together, we are making improvements in life possible.

Our story begins in 2004 with Margret Böck and Dr. Hanno Wachernig in Meerbusch, who founded Particle Metrix to offer counselling work for particle characterization. In 2006, we started developing nanoparticle analyzers. Today, we develop and manufacture our devices in Inning am Ammersee and sell them all over the world. Beside the large area of technical nanoparticles, biomedical and clinical applications play a central role. An experienced team of electrical engineers, chemists, biologists and physicists is available to the customer to competently answer all possible questions. Our instruments are installed in the best laboratories in the world and are enjoying a growing popularity. We specialized in the characterization of extracellular vesicles, exosomes, liposomes and viruses, using both scatter and fluorescence-based methods and focusing on determining the size and concentration as well as measuring zeta potential of particles in the nanometer scale.

altona Diagnostics is a medical diagnostic company that develops and manufactures in vitro diagnostic tests for the PCR based detection of pathogens such as viruses, bacteria or parasites. Headquartered in Hamburg-Altona, Germany, altona Diagnostics is privately owned and employs more than 350 people worldwide.

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bispecific immune checkpoint modulators, targeted cancer antibodies and small molecules.

BIOSYS is a pioneer in versatile bioanalytical Mulitwell plate analyzing since 1986.
Today we offer the new optical Multiwell plate analyzer BIOREADER® 7000 and EazyReader® 7000.
This system is also often used in the field of virology, for example for analyzing viral Plaque/FOCI assays or any other single cell assay in 6 - 384 well plates.

LabConsulting is based at the Vienna BioCenter in Vienna. In cooperation with our global network of manufacturers and business partners we offer you individually complete solutions for molecular diagnostics, innovations in nucleic acid extraction and qPCR, high end LabQ products as well as technical lab instrument services and repairs.

Sino Biological offers an extensive range of antigens, including viral proteins, cytokines, growth factors, and more, along with a comprehensive collection of high-quality antibodies. Specializing in protein recombinant expression and antibody development, we provide robust customized CRO services and cutting-edge technologies for accelerated pharmaceutical and pre-clinical antibody drug development.